Breast Cancer Therapeutics Market Set to Reach USD 79.77 Billion by 2030, Fueled by Advances in Treatment and Rising Incidence Rates.
The global breast cancer therapeutics market, valued at USD 30.22 billion in 2022, is projected to experience significant growth, reaching USD 79.77 billion by 2030. This substantial expansion, at a compound annual growth rate (CAGR) of 12.9% over the forecast period from 2023 to 2030, is driven by advancements in treatment modalities, increasing awareness, and rising incidence rates of breast cancer worldwide.
List of Breast Cancer Therapeutics Companies Profiled in Report:
– AstraZeneca
– Baxter Healthcare Corporation
– Bristol Myers Squiib
– Celltrion
– Eisai Co.Ltd
– Eli Lilly and Company
– Fresenius Kabi
– Genentech
– GlaxoSmithKline
– Halozyme Inc
– Kyowa Kirin
– Merck & Co
– Mylan Laboratories
– Novartis AG
– Pfizer
– Sanofi
